Characterization and formulation considerations for recombinantly derived bovine somatotropin
- PMID: 8019700
- DOI: 10.1007/978-1-4899-1236-7_2
Characterization and formulation considerations for recombinantly derived bovine somatotropin
Similar articles
-
Immunodiscrimination between native and recombinant somatotropin: a possible pathway?Vet Res Commun. 2004 Aug;28 Suppl 1:193-6. doi: 10.1023/b:verc.0000045404.78136.d3. Vet Res Commun. 2004. PMID: 15372955 No abstract available.
-
Stability and characterization of human growth hormone.Pharm Biotechnol. 1993;5:1-58. doi: 10.1007/978-1-4899-1236-7_1. Pharm Biotechnol. 1993. PMID: 8019691 Review. No abstract available.
-
Structural characterization of the two refold dimers of recombinant bovine somatotropin (bST).J Protein Chem. 1993 Apr;12(2):237-45. doi: 10.1007/BF01026046. J Protein Chem. 1993. PMID: 8489709
-
Molecular topology and dimerization of recombinant bovine somatotropin.Biopolymers. 1990;30(5-6):645-7. doi: 10.1002/bip.360300516. Biopolymers. 1990. PMID: 2265235 No abstract available.
-
Mechanisms by which somatotropin decreases adipose tissue growth.Am J Clin Nutr. 1993 Aug;58(2 Suppl):287S-295S. doi: 10.1093/ajcn/58.2.287S. Am J Clin Nutr. 1993. PMID: 8328402 Review.